Protease-triggered siRNA delivery vehicles.

The safe and efficacious delivery of membrane impermeable therapeutics requires cytoplasmic access without the toxicity of nonspecific cytoplasmic membrane lysis. We have developed a mechanism for control of cytoplasmic release which utilizes endogenous proteases as a trigger and results in functional delivery of small interfering RNA (siRNA). The delivery approach is based on reversible inhibition of membrane disruptive polymers with protease-sensitive substrates. Proteolytic hydrolysis upon endocytosis restores the membrane destabilizing activity of the polymers thereby allowing cytoplasmic access of the co-delivered siRNA. Protease-sensitive polymer masking reagents derived from polyethylene glycol (PEG), which inhibit membrane interactions, and N-acetylgalactosamine, which targets asialoglycoprotein receptors on hepatocytes, were synthesized and used to formulate masked polymer-siRNA delivery vehicles. The size, charge and stability of the vehicles enable functional delivery of siRNA after subcutaneous administration and, with modification of the targeting ligand, have the potential for extrahepatic targeting.

Is it homogeneous or heterogeneous catalysis? Compelling evidence for both types of catalysts derived from [Rh(eta5-C5Me5)Cl2]2 as a function of temperature and hydrogen pressure.

Addressed herein is the 20+ year-old question of whether the true benzene and cyclohexene hydrogenation catalysts derived from the organometallic precursor [Rh(eta5-C5Me5)Cl2]2, 1, are homogeneous or heterogeneous. The methodology employed is that developed earlier (Lin, Y.; Finke, R. G. Inorg Chem. 1994, 33, 4891, "A More General Approach to Distinguishing Homogeneous from Heterogeneous Catalysis..."). The kinetic evidence especially, but also the metal product (nanoclusters plus bulk metal), Hg0 poisoning and other experiments, provide compelling evidence that Rh0 nanoclusters are the true benzene hydrogenation heterogeneous catalyst derived from [Rh(eta5-C5Me5)Cl2]2, 1, at the required more vigorous conditions of 50-100 degrees C and 50 atm H2. However, the same methods reveal that the cyclohexene hydrogenation catalyst derived from 1 at the milder conditions of 22 degrees C and 3.7 atm H2 is a nonnanocluster, homogeneous catalyst, most likely the previously identified complex, [Rh(eta5-C5Me5)(H)2(solvent)] (Gill, D. S.; White, C.; Maitlis, P. M J. C. S. Dalton Trans. 1978, 617). In short, the present results solve the two-decade-old problem of identifying the true benzene and cyclohexene hydrogenation catalysts derived from [Rh(eta5-C5Me5)Cl2]2. Perhaps most significant is the demonstration that the methodology employed has the ability to identify both heterogeneous and homogeneous catalysts from the same catalyst precursor.